Xiamen Amoytop Biotech Co., Ltd. (SHA: 688278)

Xiamen Amoytop Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	333.25	412.96	301.24	285.42	197.16	205.89
Trading Asset Securities	251.29	257.08	270.78	196.38	268.22	-
Cash & Short-Term Investments	584.55	670.04	572.02	481.8	465.38	205.89
Cash Growth	-8.07%	17.14%	18.73%	3.53%	126.04%	41.93%
Accounts Receivable	577.91	441.02	223.05	206.28	185	141.25
Other Receivables	35.87	17.87	20.17	21.67	11.99	15.39
Receivables	613.79	458.9	243.22	227.94	196.99	156.64
Inventory	252.75	187.02	129.73	116.49	99.62	70.6
Other Current Assets	58.47	24.24	10.64	8.19	10.81	12.08
Total Current Assets	1,510	1,340	955.61	834.42	772.8	445.2
Property, Plant & Equipment	636.53	490.85	389.77	192.92	126.74	96.22
Other Intangible Assets	179.07	191.54	121.69	146.91	172.28	196.41
Long-Term Deferred Tax Assets	42.98	43.66	47.18	34.96	24.97	23.41
Long-Term Deferred Charges	210.64	176.7	229.25	169.14	78.24	23.5
Other Long-Term Assets	104.54	112.98	26.05	44.99	16.24	3.24
Total Assets	2,683	2,356	1,770	1,424	1,193	789.83
Accounts Payable	56.36	39.73	50.91	8.14	7.15	10.09
Accrued Expenses	131.3	244.46	159.55	120.4	60.94	51.74
Short-Term Debt	-	-	-	10	18.92	60.09
Current Portion of Leases	4.45	4.16	4.18	5.79	-	-
Current Income Taxes Payable	56.12	48.95	41.97	24.42	8.73	19.24
Current Unearned Revenue	62.14	60.05	7.23	5.18	3.34	6.6
Other Current Liabilities	38.94	6.31	4.05	3.3	15.86	2.97
Total Current Liabilities	349.3	403.66	267.89	177.23	114.94	150.72
Long-Term Leases	5.45	3.76	5.56	9.37	-	-
Long-Term Unearned Revenue	34.47	40.62	47.68	51.25	56.84	60.3
Long-Term Deferred Tax Liabilities	0.91	0.41	15.15	5.54	3.07	1.42
Other Long-Term Liabilities	28.63	31.25	25.99	19.53	17.48	13.83
Total Liabilities	418.77	479.69	362.27	262.91	192.33	226.27
Common Stock	406.8	406.8	406.8	406.8	406.8	360.3
Additional Paid-In Capital	397.82	397.04	397.04	397.04	397.04	113.09
Retained Earnings	1,460	1,073	603.76	357.42	196.56	90.16
Shareholders' Equity	2,265	1,876	1,408	1,161	1,000	563.55
Total Liabilities & Equity	2,683	2,356	1,770	1,424	1,193	789.83
Total Debt	9.9	7.92	9.74	25.16	18.92	60.09
Net Cash (Debt)	574.65	662.11	562.28	456.63	446.46	145.79
Net Cash Growth	-8.26%	17.76%	23.14%	2.28%	206.23%	94.23%
Net Cash Per Share	1.41	1.63	1.39	1.13	1.11	0.41
Filing Date Shares Outstanding	406.8	406.8	406.8	406.8	406.8	406.8
Total Common Shares Outstanding	406.8	406.8	406.8	406.8	406.8	360.3
Working Capital	1,160	936.53	687.72	657.19	657.86	294.48
Book Value Per Share	5.57	4.61	3.46	2.85	2.46	1.56
Tangible Book Value	2,085	1,685	1,286	1,014	828.12	367.15
Tangible Book Value Per Share	5.13	4.14	3.16	2.49	2.04	1.02
Buildings	-	135.53	118.65	21.31	22.03	24.62
Machinery	-	319.97	271.83	177.83	173.49	162.21
Construction In Progress	-	183.72	135.81	118	68.43	37.21

Source: S&P Capital IQ. Standard template. Financial Sources.